160 related articles for article (PubMed ID: 30885360)
1. Pathways- and epigenetic-based assessment of relative immune infiltration in various types of solid tumors.
Bacolod MD; Barany F; Pilones K; Fisher PB; de Castro RJ
Adv Cancer Res; 2019; 142():107-143. PubMed ID: 30885360
[TBL] [Abstract][Full Text] [Related]
2. Can CpG methylation serve as surrogate markers for immune infiltration in cancer?
Bacolod MD; Barany F; Fisher PB
Adv Cancer Res; 2019; 143():351-384. PubMed ID: 31202362
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
Fröhlich A; Loick S; Bawden EG; Fietz S; Dietrich J; Diekmann E; Saavedra G; Fröhlich H; Niebel D; Sirokay J; Zarbl R; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
EBioMedicine; 2020 Feb; 52():102647. PubMed ID: 32028068
[TBL] [Abstract][Full Text] [Related]
4. A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations.
Tamborero D; Rubio-Perez C; Muiños F; Sabarinathan R; Piulats JM; Muntasell A; Dienstmann R; Lopez-Bigas N; Gonzalez-Perez A
Clin Cancer Res; 2018 Aug; 24(15):3717-3728. PubMed ID: 29666300
[No Abstract] [Full Text] [Related]
5. Genomic Characterization of Six Virus-Associated Cancers Identifies Changes in the Tumor Immune Microenvironment and Altered Genetic Programs.
Varn FS; Schaafsma E; Wang Y; Cheng C
Cancer Res; 2018 Nov; 78(22):6413-6423. PubMed ID: 30254145
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.
Li B; Severson E; Pignon JC; Zhao H; Li T; Novak J; Jiang P; Shen H; Aster JC; Rodig S; Signoretti S; Liu JS; Liu XS
Genome Biol; 2016 Aug; 17(1):174. PubMed ID: 27549193
[TBL] [Abstract][Full Text] [Related]
7. Using epigenomics data to predict gene expression in lung cancer.
Li J; Ching T; Huang S; Garmire LX
BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S10. PubMed ID: 25861082
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers.
Ekiz HA; Huffaker TB; Grossmann AH; Stephens WZ; Williams MA; Round JL; O'Connell RM
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30721153
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Cancer Vaccines-T Cell Responses and Epigenetic Modulation.
Kartikasari AER; Prakash MD; Cox M; Wilson K; Boer JC; Cauchi JA; Plebanski M
Front Immunol; 2018; 9():3109. PubMed ID: 30740111
[TBL] [Abstract][Full Text] [Related]
10. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
[TBL] [Abstract][Full Text] [Related]
11. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract][Full Text] [Related]
12. An integrated pan-cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity.
Liu JN; Kong XS; Sun P; Wang R; Li W; Chen QF
J Cell Mol Med; 2021 Feb; 25(4):2082-2097. PubMed ID: 33373169
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
14. Insights from multidimensional analyses of the pan-cancer DNA methylome heterogeneity and the uncanonical CpG-gene associations.
Liu Y; Huang R; Liu Y; Song W; Wang Y; Yang Y; Dong S; Yang X
Int J Cancer; 2018 Dec; 143(11):2814-2827. PubMed ID: 30121964
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cells.
McGuire MH; Herbrich SM; Dasari SK; Wu SY; Wang Y; Rupaimoole R; Lopez-Berestein G; Baggerly KA; Sood AK
EBioMedicine; 2019 May; 43():127-137. PubMed ID: 31056473
[TBL] [Abstract][Full Text] [Related]
16. A systematic analysis of immune genes and overall survival in cancer patients.
Wang Q; Li P; Wu W
BMC Cancer; 2019 Dec; 19(1):1225. PubMed ID: 31842801
[TBL] [Abstract][Full Text] [Related]
17. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of IQGAP2 and higher expression of IQGAP3 correlates with poor prognosis in cancers.
Kumar D; Hassan MK; Pattnaik N; Mohapatra N; Dixit M
PLoS One; 2017; 12(10):e0186977. PubMed ID: 29073199
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer analysis of frequent DNA co-methylation patterns reveals consistent epigenetic landscape changes in multiple cancers.
Zhang J; Huang K
BMC Genomics; 2017 Jan; 18(Suppl 1):1045. PubMed ID: 28198667
[TBL] [Abstract][Full Text] [Related]
20. A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors.
Jia Y; Tian Q; Yang K; Liu Y; Liu Y
Biomed Res Int; 2021; 2021():5862941. PubMed ID: 34845438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
